View Post

HHV-6B saliva viral loads peak 3-7 months after primary infection

In All, Epidemiology by Kristin Loomis

A new study on HHV-6B shedding in saliva during and after exanthema subitum found that peak detection rates and viral loads occurred during the convalescent period, between 3 to 7 months post-illness. Detection rates were lower in adults than in children suggesting that siblings may be more likely to transmit the virus than parents.

View Post

Low dose emetine shows promise as a herpesvirus antiviral

In All, Latest Scientific News, Treatments - Antiviral by Kristin Loomis

Investigators at Johns Hopkins have determined that emetine, an older drug used to treat dysentery as well as to induce vomiting, is also effective against cytomegalovirus (CMV/HHV-5). Not only was emetine effective at an extremely low dose, it demonstrated a synergistic effect when combined with ganciclovir in a mouse model of CMV infection and it worked at a much earlier stage of viral replication than the drugs currently in use.

View Post

HHV-7 homolog found in the peripheral nerve ganglia of macaques

In All, Animal Models, CNS Disease by Kristin Loomis

Virologists led by Serge Barcy, PhD at the Seattle Children’s Research Institute and University of Washington have identified a homolog for HHV-7 in pigtail macaques They were surprised to learn that it could be detected in the peripheral nerve ganglia, and hope to use their new animal model to explore how HHV-7 might play a role in demyelinating diseases.

View Post

HHV-6 reactivation tied to early hypogammaglobulinemia in drug hypersensitivity syndrome

In All, Drug Hypersensitivity, Immunology by Kristin Loomis

A Spanish study of drug-induced eosinophilia found that early hypogammaglobulinemia was associated with subsequent HHV-6 reactivation in patients with severe drug hypersensitivity syndromes. This study of 274 cases at La Paz University Hospital in Madrid confirms earlier reports from Japan and France that described transient reductions of total IgG at the outset of drug hypersensitivity reactions leading to HHV-6 reactivation.

View Post

HHV-6A gene activity linked to central nervous system disease

In All, CNS Disease, Latest Scientific News by Kristin Loomis

Chinese investigators from Nanjing Medical University report that HHV-6A infection of astrocytes are associated with differences in gene expression that are also found in several CNS diseases including Alzheimer’s, glioma and multiple sclerosis. The investigators used gene ontology analysis to determine the biological processes, cellular components, and molecular functions of the differentially expressed genes and signalling pathways.

View Post

EBV and HHV-6B but no CMV found in astrocytomas by digital droplet PCR

In All, Cancer, CNS Disease, Latest Scientific News by Kristin Loomis

A group from the National Institute of Neurological Disorders and Stroke, NIH, has reported finding Epstein-Barr Virus (EBV) and HHV-6 but no cytomegalovirus (CMV) in astrocytomas, a brain tumor comprising approximately one quarter of all gliomas diagnosed. The group used digital droplet PCR (ddPCR), a technique that is highly precise but less sensitive than nested PCR and immunohistochemistry, techniques that have been used in previous studies.

View Post

Genome editing to clear latent herpesvirus infection

In All, Genes & Proteins, Treatments - Antiviral by Kristin Loomis

A group from the University Medical Center in the Netherlands has shown that new gene editing technology can be used to impair viral replication and clear latent herpesvirus infections. The group used a CRISPR-Cas system to target viral genetic elements that completely eliminated CMV and HSV1 replication. They were also able to clear latent EBV from transformed human tumor cells.

View Post

HHV-6A infection of the uterus linked to infertility

In All, Endocrine Conditions, Host Cell Interaction, Infertility & Miscarriage by Kristin Loomis

A new study reported that HHV-6A infects the lining of the uterus in 43% of women with unexplained infertility but cannot be found in uterine lining of fertile women.  Furthermore, the cytokine and the natural killer cell profiles were very different in patients with the infection. HHV-6A was found only in uterine endothelial cells, and not in the blood.

View Post

HHV-6, EBV and CMV found in GI tract cancers

In All, Liver Disease, Uncategorized by Kristin Loomis

A group from Washington University used a bioinformatics system called VirusScan to analyze RNA-Seq data sets from 6,813 human tumors compared to those of adjacent normal tissue. Tumor samples representing 23 different forms of cancer were analyzed. HHV-6, EBV and CMV were found at significantly high levels in GI tract cancer tissue.

View Post

Surprise finding : HHV-6 telomeric repeats are crucial for HHV-6 integration

In All, ciHHV-6, Latest Scientific News, Molecular Biology by Kristin Loomis

When the research team led by Benedikt Kaufer attempted to shed light on the mechanism behind HHV-6 integration, they were suprised to find telomeric repeats were critical to the integration process. Since the U94 gene shares homology and biological properties with the adenovirus Rep68 gene responsible for viral integration into human chromosomes, U94 was considered the most likely candidate to mediate HHV-6 integration.

View Post

CXCL11 and CCL2 are specific to HHV-6B in febrile infants

In All, Alzheimer's Disease, Multiple Sclerosis by Kristin Loomis

Japanese investigators from Kobe University identified CXC11 as a chemokine uniquely expressed in primary HHV-6B infections. They also confirmed a previous finding that cytokine CCL2 (MCP-1) plays a role in HHV-6B primary infections. Both CXCL11 and CCL2 are expressed in several neuroinflammatory conditions including epilepsy, Alzheimer’s disease and traumatic brain injury.

View Post

The crystal structure of HHV-6B U14 defined

In All, Genes & Proteins, Molecular Biology by Kristin Loomis

A group led by Yasuko Mori in Japan has analyzed the crystal structure of HHV-6B U14, an important accomplishment for the understanding of HHV-6. Human herpesvirus 6B encodes numerous tegument proteins that make up the viral matrix. One of these tegument proteins is U14. In addition to being necessary for viral propagation, it is able to regulate host cell responses by interacting with host factors such as tumor suppressor p53.

View Post

Does CD134 upregulation explain why HHV-6 reactivates preferentially in DRESS/ DIHS?

In All, Drug Hypersensitivity, Latest Scientific News, Skin Conditions, Transplant Complications by Kristin Loomis

It has long been a mystery why HHV-6 is preferentially reactivated in drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug induced hypersensitivity syndrome (DIHS). HHV-6 reactivation occurs in over 60% of severe cases and is part of the definition of DIHS in Japan. Investigators in Japan suspect that the explanation may lie with the CD134 receptor on activated CD4 cells.

View Post

GAD antibodies & HHV-6 limbic encephalitis – a case of molecular mimicry?

In All, Autoimmune Disease, CNS Disease, CNS Dysfunction, Encephalitis & Encephalopathy, Epilepsy and Seizures, Host Cell Interaction by Kristin Loomis

A fifth case of limbic encephalitis associated with GAD antibodies and HHV-6 infection has been reported, this time in an immunocompetent woman with chromosomally integrated HHV-6, epilepsy, and psychosis. The patient’s condition improved (with a drop in GAD antibody titers and stabilization of psychotic symptoms) in response to three weeks of antiviral therapy but relapsed when antiviral therapy was withdrawn.